Skip to main content

Fiscal Wizard · Single-issue tearsheet

RNA / Jun 21, 2026 Run #7477

RNA

Atrium Therapeutics, Inc.

Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. The company was incorporated in 2025 and is headquartered in San Diego, California.

Composite verdict

D 38.7 / 100
Mixed setup · Reversal 21 drivers · 1 gate blocking
  • Parabolic SAR Flip
  • Elder Force Index
  • Declining Volume
  • Accumulation/Distribution Line
  • Stochastic RSI
  • MA Rejection
Stand aside Setup or conviction grade does not support a directional trade.

Industry rank 115th of 598 in Biotechnology

rescore-sweep
Technical synthesis
Bull 36%Evidence: Low · 27 signals64% Bear
Momentum Bearish 32Mean-reversion Neutral 53

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

34.6 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Greenblatt ROC 75
Free Cash Flow Yield 0
EV/Sales 75
P/S Ratio 25
P/B 75
Return on Equity 25

Technicals Neutral

42.8 / 100

Mixed setup — bull and bear signals both survive the gates. No clean directional edge. · 43 signals shown.

Strongest
Weakest
Parabolic SAR Flip 89
Accumulation/Distribution Line 9
Elder Force Index 89
Vortex Signal 13
Sushi Roll 88
Coppock Curve 13

Risk Gates

1 blocking 4 caution

1 guard active, 2 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Sloan Ratio Caution

Visual accruals-quality flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for RNA.